ClinicalTrials.gg
DrugBiological

Burosumab clinical trials

Also written KRN23, Crysvita and UX023.

studies test it
26
open now
0
in phase 3
8
first study started
2008

How each study uses burosumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
17 Apr 2018 · CRYSVITA · BLA 761068 (FDA, Drugs@FDA)
European Union
19 Feb 2018 · Crysvita · EMEA/H/C/004275 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Burosumab
16

Brand

Crysvita
14

Development codes

KRN23
19
UX023
6

Studies by the year they started

26 studies that test it; most in 2015 (4)

Studies that test burosumab, by start year
YearStudies
20081
20111
20121
20142
20154
20163
20171
20183
20193
20202
20213
20222

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
9
Phase 3
8
Phase 4
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 7

Kyowa Kirin Co., Ltd. (10) · Kyowa Kirin, Inc. (7) · Kyowa Kirin Pharmaceutical Development Ltd (2) · Laura Tosi (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · Yale University (1) · Wuerzburg University Hospital (1) · University of Alabama at Birmingham (1)

Studies

Open first, then newest update. How each study uses burosumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test burosumab →

Codes

What other systems call burosumab · ClinicalTrials.gg INT000328

  • MeSH (NLM) C000601956burosumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) G9WJT6RD29BUROSUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2043855Confirmed FDA, Wikidata
  • Wikidata Q28209068BurosumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C119744BurosumabOne source FDA
  • DrugBank DB14012One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.